83bar
83bar is the patient activation company
05/26/2026
AI may speed up clinical trial operations, but patient recruitment still needs a smarter human + digital pathway.
Patients don’t move forward just because trial systems move faster.
They need education, validation, support, and a clear next step before sites inherit the burden.
In our latest whitepaper, 83bar explores how patient activation helps sponsors turn faster trial intelligence into better-qualified patient progression.
Learn more here:
Why Do Referrals Fail Before Screening Even Begins? Why More Referrals Won’t Fix Trial Qualification
04/22/2026
More referrals do not always mean better trial enrollment. Sometimes the real problem is what happens before screening even begins.
Our latest blog breaks down how patient activation helps reduce screen failures, improve qualification, and support sites with more site-ready patients.
Read the full blog here: https://hubs.ly/Q04d1YHs0
Meet Jeff Hoffman, vice president of commercial development and strategic partnerships for 83bar. This short clip introduces Jeff and discusses a bit about his role. To learn more about Jeff, view the full video at: http://ow.ly/viiA50GEcwF
11/04/2021
The National Institute of Diabetes and Digestive and Kidney Diseases estimates that 30.3 million people in the U.S. have diabetes and 84.1 million Americans 18 years and older have prediabetes.
83bar has worked with clients focused on solutions for diabetic nephropathy. Read the market report: https://www.83bar.com/market-report-diabetic-nephropathy/?utm_source=facebook&utm_medium=social-organic&utm_campaign=market-report
Learn more about diabetes at https://www.niddk.nih.gov/health-information/diabetes
After hearing 83bar employees explain why they like working at the company, explore the Careers section on our website at https://www.83bar.com/careers We're hiring!
10/26/2021
This whitepaper covers issues related to patient recruitment and retention for clinical trials. Did you know:
• 50% of trials are delayed due to patient recruitment issues
• 85% of clinical trials fail to retain enough patients to continue
Read the paper to learn how to beat the averages.
http://ow.ly/sZRw50GxY6p
10/22/2021
Recently 83bar presented a case study and discussed patient activation at the Future of Preventive Medicine and Public Health medical conference, which streamed live from Berlin, Germany. This article summarizes additional papers presented there.
Read full article here: https://www.83bar.com/patient-activation-and-other-health-technology-topics/?utm_source=facebook&utm_medium=social-organic&utm_campaign=blog
10/20/2021
This blog article discusses the steps the FDA has taken to advance digital health technology, including launching the Digital Health Center of Excellence. The article also looks at Software as Medical Device and how the FDA regulates SaMD.
Read the full blog here: http://ow.ly/sAnY50Gttrp
10/19/2021
72% of patients would likely participate in clinical trials if they were recommended to by their doctor. But only 24% say they had heard of trials from their doctor. Read the whitepaper and then visit http://ow.ly/8cH850Gtsji to learn about 83bar's clinical trial solutions.
Download the whitepaper here: http://ow.ly/vNCw50Gtsjh
10/15/2021
Matt Mood, senior developer at 83bar, asserts in this video clip that we are there for our clients. We will even go so far as to develop custom logic to help clients achieve their goals.
Watch the video here: http://ow.ly/cmsx50GrXgO
Click here to claim your Sponsored Listing.
Category
Contact the business
Telephone
Website
Address
11211 Taylor Draper Lane, Suite 115
Austin, TX
78759